The Montreal Cognitive Asesment (MoCA) as a measure of severity of amnesia in patients with alcohol-related cognitive impairments and Korsakof syndrome

Clinical Neuropsychiatry

Volumn 10, Issue 3-4, 2013, Pages 134-141

  Wester, Arie J ^a,b   Westhoff, Josette ^a,b   Kessels, Roy P C ^a,b,c   Egger, Jos I M ^a,b,d,e  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^e Pompe Institute for Forensic Psychiatry   (Netherlands)

Author keywords

Alcohol use disorder (AUD); Korsakoff syndrome; Memory disorder; Neuropsychological assessment; Screening

Indexed keywords

ADULT; AGED; ALCOHOL USE DISORDER; AMNESIA; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CONVERGENT VALIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; KORSAKOFF PSYCHOSIS; MALE; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALIDITY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RIVERMEAD BEHAVIORAL MEMORY TEST; SENSITIVITY AND SPECIFICITY;

EID: 84885048609     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Acevedo A, Loewenstein DA, Agron J, Duara R (2007). Influence of sociodemographic variables on neuropsychological test performance in Spanish-speaking older adults. Journal of Clinical and Experimental Neuropsychology 29, 530-544.
2. Baddeley AD. The psychology of memory. In Baddeley AD, Wilson BA, Kopelman M (Eds) (2002). Handbook of memory disorders. Psychology Press, Hove.
3. Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D (2005). Short-term neuropsychological recovery in clients with substance use disorders. Alcoholism: Clinical and Experimental Research 29, 367-377.
4. Blake H, McKinney M, Treece K, Lee E, Lincoln NB (2002). An evaluation of screening measures for cognitive impairment after stroke. Age and Ageing 31, 451-456.
5. Blansjaar BA, Horjus MC, Nijhuis HGJ (1987). Prevalence of the Korsakoff syndrome in The Hague, The Netherlands. Acta Psychiatrica Scandinavica 75, 6, 604-607.
6. Block RI, Erwin WJ, Ghoneim MM (2002). Chronic drug use and cognitive impairments. Pharmacology, Biochemistry and Behavior 73, 491-504.
7. Bouma A, Mulder J, Lindeboom J, Schmand B (Eds) (2012). Handboek Neuropsychologische Diagnostiek [Handbook Neuropsychological Assessment]. Pearson, Amsterdam.
8. Copersino M L, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD (2009). Rapid cognitive screening of patients with substance use disorders. Experimental and Clinical Psychopharmacology 17, 337-344.
9. Freitas S, Simoes MR, Alves L, Santana I (2013). Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer Disease. Alzheimer Disease & Associated Disorders 27, 1, 37-43.
10. Folstein MF, Folstein SE, McHugh PR (1975). Mini-mental state-a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
11. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. (2010). Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatrics & Gerontology International 10, 225-232.
12. Ganguli M, Snitz BE, Lee CW, Vanderbilt J, Saxton JA, Chang CC (2010). Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team. Aging & Mental Health 14, 100-107.
13. Kopelman MD (2002). Disorders of memory. Brain 125, 2152-2190.
14. Lee JY, Lee DW, Cho SJ, Na DL, Jeon HJ, Kim SK, et al. (2008). Brief screening for mild cognitive impairment in elderly outpatient clinic: Validation of the Korean version of the Montreal cognitive assessment. Journal of Geriatric Psychiatry and Neurology 21, 104-110.
15. Lezak MD, Howieson DB, Bigler ED, Tranel D (2012). Neuropsychological assessment, 5th edition. Oxford University Press, New York.
16. Luis CA. Keegan AP, Mullan M (2009). Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry 24, 197-201.
17. Mesulam MM (2008). Memory Loss. In Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, JamesonJL, Loscalzo J (Eds) Harrison's Principles of Internal Medicine. The McGraw-Hill Companies, New York.
18. Munro CA, Saxton J, Butters MA (2000). The neuropsychological consequences of abstinence among older alcoholics: a crosssectional study. Alcoholism: Clinical and Experimental Research 24, 1510-1516.
19. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for Mild Cognitive Impairment. Journal of the American Geriatrics Society 53, 4, 695-699.
20. Oscar-Berman M, Kirkley SM, Gansler DA, Couture A. (2004). Comparisons of Korsakoff and non-Korsakoff Alcoholics on Neuropsychological Tests of Prefrontal B rain Functioning. Alcoholism: Clinical & Experimental Research 28, 667-675.
21. Shulman K (2000). Clock-Drawing: is it the ideal cognitive screening test? International Journal of Geriatric Psychiatry 15, 548-561.
22. Thissen AJAM, van Bergen F, de Jonghe JFM, Kessels RPC, Dautzenberg PLJ (2010). Bruikbaarheid en validiteit van de Nederlandse versie van de Montreal Cognitive Assessment (MoCA-D) bij het diagnosticeren van Mild Cognitive Impairment [Applicability and validity of the Dutch version of the Montreal Cognitive Assessment (MoCA-D) in diagnosing MCI. Dutch Journal of Gerontology and Geriatrics 41, 231-240.
23. Verhage F (1964). Intelligentie en leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar [Intelligence and age: A study in Dutch with age twelve to seventyseven]. Van Gorcum, Assen, The Netherlands.
24. Walvoort SJW, Wester AJ, Egger JIM (2013). Neuropsychologische diagnostiek en cognitieve functies bij alcohol abstinentie [The neuropsychology of cognitive functions in alcohol abstinence. Dutch Journal of Psychiatry]. Tijdschrift voor Psychiatrie 55, 101-111.
25. Wester AJ, Van Herten JC, Egger JIM, Kessels RPC (2013a). Applicability of the Rivermead Behavioural Memory Test-Third Edition (RBMT-3) in Korsakoff's syndrome and chronic alcoholics. Neuropsychiatric Disease and Treatment 9, 875-881.
26. Wester AJ, Leenders P, Egger, JIM, Kessels, RPC (2013b). Ceiling and Floor effects on the Rivermead Behavioural memory Test in patients with alcohol-related memory disorders and healthy participants. International Journal of Psychiatry in Clinical Practice. DOI: 10.3109/13651501.2013.813553.
27. Wilson BA, Greenfield E, Clare L, Baddeley A, Cockburn J, Watson P, Tate R, Sopena S, Nannery R (2008). The Rivermead Behavioural Memory Test. Third Edition (RBMT-3). Pearson Assessment, London.